COVID-19 vaccines: wealthier nations, including the UK, must drop their opposition to the proposed TRIPS waiver at the WTO
lse.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.ac.uk Daily Mail and Mail on Sunday newspapers.
The TRIPS Intellectual Property Waiver Proposal: Creating the Right Incentives in Patent Law and Politics to end the COVID-19 Pandemic
infojustice.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infojustice.org Daily Mail and Mail on Sunday newspapers.
No patent waiver, but here are the alternatives vaccine makers are offering for Covid shots
Proposal for intellectual property & and patent rights waiver was first introduced at WTO in 2020 by India and South Africa. It has been opposed by US and Europe.
Kairvy Grewal 27 April, 2021 3:25 pm IST Text Size:
A+
New Delhi: Members of the World Trade Organization (WTO) met last week and continued their resistance towards India and South Africa’s proposal to waive intellectual property (IP) and patent rights on Covid-19 vaccines.
Instead, vaccine makers have offered alternatives such as technology transfer and licences Serum Institute of India, for example, manufactures Covishield under a licence from AstraZeneca, which developed it with Oxford University researchers to boost the global immunisation effort.